West Virginia University School of Medicine Charleston Division — Charleston, West Virginia

West Virginia University School of Medicine Charleston Division is a clinical research site located in Charleston, West Virginia, United States 25304.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

West Virginia University School of Medicine Charleston Division has participated in 1 clinical trials.

Therapeutic areas: Height Phobia.

Sponsors: CAMC Health System.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charleston

Browse all research sites in West Virginia · View every site in Charleston

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for West Virginia University School of Medicine Charleston Division?

West Virginia University School of Medicine Charleston Division has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has West Virginia University School of Medicine Charleston Division conducted?

West Virginia University School of Medicine Charleston Division has 1 clinical trials on record. Their work covers Height Phobia.

Is West Virginia University School of Medicine Charleston Division accredited by Crixeo Clinical Trials?

West Virginia University School of Medicine Charleston Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about West Virginia University School of Medicine Charleston Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.